|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.58 CNY | +7.73% |
|
+17.67% | -8.14% |
| May. 25 | Taiji Industry Gets China Supplementary Nod for Heart Failure Injection | MT |
| May. 14 | Chongqing Taiji Industry Gets China Nod for Diabetes Tablets | MT |
| Market Cap | 9.14B 1.35B 1.18B 1.09B 1B 1.91B 129B 1.94B 13B 5.1B 63.35B 5.06B 4.95B 218B | P/E 2026 * |
33.2x | P/E 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 9.14B 1.35B 1.18B 1.09B 1B 1.91B 129B 1.94B 13B 5.1B 63.35B 5.06B 4.95B 218B | EV / Sales 2026 * |
0.84x | EV / Sales 2027 * | 0.8x |
| Free-Float |
59.93% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +7.73% | ||
| 1 week | +17.67% | ||
| Current month | +22.18% | ||
| 1 month | +27.34% | ||
| 3 months | +0.67% | ||
| 6 months | -11.05% | ||
| Current year | -8.14% |
| 1 week | 13.42 | 16.6 | |
| 1 month | 11.56 | 16.6 | |
| Current year | 11.56 | 19.27 | |
| 1 year | 11.56 | 25.51 | |
| 3 years | 11.56 | 54.5 | |
| 5 years | 11.56 | 68.44 | |
| 10 years | 7.81 | 68.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Yu
CEO | Chief Executive Officer | 53 | 2021-05-18 |
Jian Yu
DFI | Director of Finance/CFO | - | 2025-10-24 |
Wang Xu
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Min Yu
CHM | Chairman | 53 | 2024-06-25 |
Kan Wang
BRD | Director/Board Member | 41 | 2021-05-18 |
Ze Jun Li
BRD | Director/Board Member | 51 | 2021-05-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +7.73% | +17.67% | -23.17% | -68.86% | 1.35B | ||
| -2.33% | -2.09% | +49.88% | +170.51% | 1,060B | ||
| -0.82% | -2.30% | +63.79% | +62.00% | 619B | ||
| -0.73% | -4.98% | +28.91% | +82.99% | 438B | ||
| +0.33% | -1.17% | +31.07% | +27.09% | 333B | ||
| -0.02% | -2.85% | +29.15% | +45.24% | 282B | ||
| -3.89% | -11.22% | +22.81% | +27.30% | 267B | ||
| +0.66% | -1.42% | -26.59% | -37.71% | 218B | ||
| -0.06% | -2.88% | +23.07% | +62.33% | 196B | ||
| -3.72% | -1.10% | +18.41% | +70.56% | 161B | ||
| Average | -0.28% | -1.34% | +21.73% | +44.14% | 357.53B | |
| Weighted average by Cap. | -1.31% | -2.95% | +36.73% | +83.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.88B 1.6B 1.4B 1.29B 1.2B 2.27B 153B 2.31B 15.47B 6.07B 75.38B 6.02B 5.89B 259B | 11.4B 1.68B 1.47B 1.36B 1.25B 2.38B 160B 2.42B 16.21B 6.37B 79.03B 6.32B 6.18B 272B |
| Net income | 275M 40.56M 35.48M 32.72M 30.22M 57.35M 3.87B 58.31M 391M 154M 1.91B 152M 149M 6.55B | 510M 75.22M 65.79M 60.68M 56.05M 106M 7.17B 108M 725M 285M 3.53B 282M 276M 12.15B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | CN¥16.58 | +7.73% | 52,807,665 |
| 26-07-09 | CN¥15.39 | +2.87% | 55,293,956 |
| 26-07-08 | CN¥14.96 | +10.00% | 22,555,068 |
| 26-07-07 | CN¥13.60 | -5.03% | 15,439,457 |
| 26-07-06 | CN¥14.32 | +1.63% | 23,670,239 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600129 Stock
Select your edition
All financial news and data tailored to specific country editions
















